Clinical Trial Update: PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy Volunteers [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluated PET/CT imaging with BAY1075553 to assess safety, tolerability, and diagnostic performance in patients with prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BAY1075553

Snippet

Sponsor: Life Molecular Imaging SA | Conditions: Diagnostic Imaging | Phase 1 | Status: COMPLETED